FDA Inspection
SOFIE Co. dba SOFIESOFIE Co. dba SOFIE – FDA Inspection, Apr 21, 2026
Record Details
This FDA Inspection record concerns SOFIE Co. dba SOFIE, with an inspection on April 21, 2026, issued by the Dallas District Office, covering human drugs.
- Office
- Dallas District Office
- Person
View Company Profile
ID · 9f97f7aa-21b4-490d-9d7d-a4ffd9f3575a
Inspection Facts
- Inspection number
- 1313566
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
1- 21 CFR 212.30(b)Equipment procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of SOFIE Co. dba SOFIE
3| Date | Classification | Office | Project area |
|---|---|---|---|
| January 15, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 27, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 22, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for SOFIE Co. dba SOFIE
- FDA Inspection 1076429 - 2019-01-15
- FDA Inspection 970671 - 2016-05-27
- FDA Inspection 854064 - 2013-10-22
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.